Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Efrosini Fostieri"'
1
Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies
Autor: Efrosini Fostieri, David Beeson, Socrates J. Tzartos, Avgi Mamalaki, Sonia Berrih-Aknin
In the autoimmune disease myasthenia gravis (MG), antibodies against the muscle nicotinic acetylcholine receptor (AChR) cause loss of functional AChR in the neuromuscular junction. To isolate AChR-specific human antibody fragments (Fab), a phage-disp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb7bf0df12e42e3d829cd4a98c67f47
https://ora.ox.ac.uk/objects/uuid:615ab3fe-7305-481d-a69e-09f7225c156a
Zobrazit plný text záznamu
2
Recent advances in the understanding and therapy of myasthenia gravis
Autor: Konstantinos Poulas, Kalliopi Kostelidou, Efrosini Fostieri, Socrates J. Tzartos
Publikováno v: Future Neurology. 1:799-817
Myasthenia gravis (MG) is a T-cell dependent autoimmune disease mediated by autoantibodies, which mainly target muscle nicotinic acetylcholine receptors (AChR) and cause loss of functional AChRs in the neuromuscular junction. Both MG and its major au
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c37b7581745c1daace31f361d888783
https://doi.org/10.2217/14796708.1.6.799
Zobrazit plný text záznamu
3
The conformation of the main immunogenic region on the α-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits
Autor: Efrosini Fostieri, Socrates J. Tzartos, David Beeson
Publikováno v: FEBS Letters. 481:127-130
Myasthenia gravis (MG) is caused by autoantibodies to the acetylcholine receptor (AChR). Experiments with fetal (alpha(2)betagammadelta) and adult (alpha(2)betaepsilondelta) AChR and with recombinant subunit dimers showed that some monoclonal antibod
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f681ef607b5dbeaa7f2f3c20868b3f7
https://doi.org/10.1016/s0014-5793(00)01980-3
Zobrazit plný text záznamu
4
Emerging Therapies for the Treatment of Autoimmune Myasthenia Gravis
Autor: Anastasia Sideri, Kalliopi Kostelidou, Efrosini Fostieri, Konstantinos Lazaridis, Socrates J. Tzartos
Publikováno v: Clinical Applications of Immunomics ISBN: 9780387792071
Myasthenia gravis (MG) is an autoimmune disease mediated by autoantibodies that mainly target muscle nicotinic acetylcholine receptor (AChR) and cause loss of functional AChRs in the neuromuscular junction. Despite extensive knowledge from studies on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9c49e40b41b6788d3bd161bb729b06a
https://doi.org/10.1007/978-0-387-79208-8_9
Zobrazit plný text záznamu
5
Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity
Autor: Efrosini Fostieri, Konstantinos Lazaridis, Socrates J. Tzartos, George Lagoumintzis, Marios Zouridakis, Dimitra Kalamida, Anastasia Sideri, Vassiliki Avramopoulou, Konstantinos Poulas
Publikováno v: The FEBS journal. 274(15)
Nicotinic acetylcholine receptors (nAChRs) are integral membrane proteins and prototypic members of the ligand-gated ion-channel superfamily, which has precursors in the prokaryotic world. They are formed by the assembly of five transmembrane subunit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992429ab14c70087beab0a7499232a75
https://pubmed.ncbi.nlm.nih.gov/17651090
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje